Join
Live feed
·
INSIDERFilingvia Quantisnow
Fulcrum Therapeutics Inc. logo

Director Ezekowitz Alan sold $65,614 worth of shares (18,000 units at $3.65) as part of a pre-agreed trading plan, decreasing direct ownership by 62% to 10,927 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
FULC· Fulcrum Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FULC (Fulcrum Therapeutics Inc.) and more on Quantisnow.